Sequel Med Tech has announced that it has agreed to integrate its twiist automated insulin delivery system with Abbott‘s glucose-ketone sensor, which is currently under
A new device based on research from Indiana University could one day supplement current methods to provide better protection against more serious swings in blood
Insulet Corporation has announced that its Omnipod 5 is now compatible with the Dexcom G7 Continuous Glucose Monitor (CGM) in the UK and Netherlands. The
IR-MED has secured a $500,000 grant from the Israel Innovation Authority (IIA) to advance the development of DiaSafe, an AI-powered device which uses noninvasive spectrographic
A study has found that a new technology that allows a artificial pancreas system to adapt to users’ changing bodies – and lets users test
A new partnership has led to the development of the first-ever automated insulin delivery (AID) system that incorporates a one-year glucose sensor. Sequel Med Tech,
A new partnership has led to the development of the first-ever automated insulin delivery (AID) system that incorporates a one-year glucose sensor. Sequel Med Tech,
Bioling, a health technology company developing wearable biosensors for metabolic health has announced it has secured $100m in funding for a wearable patch that evaluates
The US Food and Drug Administration has cleared the extended-wear Dexcom G7 device for adult users The Dexcom G7 continuous glucose monitor (CGM) will now
ViCentra B.V., the company behind Kaleido, the insulin patch pump and automated insulin delivery (AID) system, has announced the appointment of Tom Arnold as Chief